Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2007 1
2012 1
2013 1
2016 1
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Results by year
Filters applied: . Clear all
Page 1
Natural products: a continuing source of novel drug leads.
Cragg GM, Newman DJ. Cragg GM, et al. Biochim Biophys Acta. 2013 Jun;1830(6):3670-95. doi: 10.1016/j.bbagen.2013.02.008. Epub 2013 Feb 18. Biochim Biophys Acta. 2013. PMID: 23428572 Free PMC article. Review.
Combinatorial chemistry (late 1980s), shifted the focus of drug discovery efforts from Nature to the laboratory bench. SCOPE OF REVIEW: This review traces natural products drug discovery, outlining important drugs from natural sources tha …
Combinatorial chemistry (late 1980s), shifted the focus of drug discovery efforts from Nature to the laboratory bench. SCOPE OF REVIE …
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019.
Newman DJ, Cragg GM. Newman DJ, et al. Among authors: cragg gm. J Nat Prod. 2020 Mar 27;83(3):770-803. doi: 10.1021/acs.jnatprod.9b01285. Epub 2020 Mar 12. J Nat Prod. 2020. PMID: 32162523
From the data presented in this review, the utilization of natural products and/or synthetic variations using their novel structures, in order to discover and develop the final drug entity, is still alive and well. ...In the 1981 to date time frame the …
From the data presented in this review, the utilization of natural products and/or synthetic variations using their novel
Natural Products as Sources of New Drugs from 1981 to 2014.
Newman DJ, Cragg GM. Newman DJ, et al. Among authors: cragg gm. J Nat Prod. 2016 Mar 25;79(3):629-61. doi: 10.1021/acs.jnatprod.5b01055. Epub 2016 Feb 7. J Nat Prod. 2016. PMID: 26852623 Review.
FDA (and similar organizations). From the data presented in this review, the utilization of natural products and/or their novel structures, in order to discover and develop the final drug entity, is still alive and well. ...In other areas, the influenc …
FDA (and similar organizations). From the data presented in this review, the utilization of natural products and/or their n
Natural products as sources of new drugs over the last 25 years.
Newman DJ, Cragg GM. Newman DJ, et al. Among authors: cragg gm. J Nat Prod. 2007 Mar;70(3):461-77. doi: 10.1021/np068054v. Epub 2007 Feb 20. J Nat Prod. 2007. PMID: 17309302 Review.
From the data presented, the utility of natural products as sources of novel structures, but not necessarily the final drug entity, is still alive and well. Thus, in the area of cancer, over the time frame from around the 1940s to date, of the 1 …
From the data presented, the utility of natural products as sources of novel structures, but not necessarily the …
Natural products as sources of new drugs over the 30 years from 1981 to 2010.
Newman DJ, Cragg GM. Newman DJ, et al. Among authors: cragg gm. J Nat Prod. 2012 Mar 23;75(3):311-35. doi: 10.1021/np200906s. Epub 2012 Feb 8. J Nat Prod. 2012. PMID: 22316239 Free PMC article. Review.
From the data presented, the utility of natural products as sources of novel structures, but not necessarily the final drug entity, is still alive and well. Thus, in the area of cancer, over the time frame from around the 1940s to date, of the 1 …
From the data presented, the utility of natural products as sources of novel structures, but not necessarily the …
Natural product drug discovery in the next millennium.
Cragg GM, Newman DJ. Cragg GM, et al. Pharm Biol. 2001;39 Suppl 1:8-17. doi: 10.1076/phbi.39.s1.8.0009. Pharm Biol. 2001. PMID: 21554167
With the development of new molecular targets based on these proteins, there is an increasing demand for novel molecular diversity for screening. Natural products will play a crucial role in meeting this demand through the continued investigation of wo …
With the development of new molecular targets based on these proteins, there is an increasing demand for novel molecular diversity fo …